|
|
|
|
| XTP-242e | Top 4 types of cancer (colon, breast, lung and prostate) with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing TP242d | | Cores | 24 | Cases | 24 | | Row number | 4 | Column number | 6 | | Core Diameter(mm) | 1.5 | Thickness(µm) | 5.0 | | Tissue Array Type | FFPE | Species | Human | | QA/QC | H&E and IHC confirmed | | Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | | Notes | 1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 60 minutes at 65℃ before the experiment. 3.Please choose a gentle repair method to avoid tissue detachment. |
|
|
| |
|
Legend:
|
Pro -Prostate Lun -Lung Bre -Breast Col -Colon |
Malignant (IB) Malignant (IIA) Malignant (IIB) Malignant (III) Malignant (IIIB) Malignant (IIIC) NAT (*) Normal (*) |
|
|
|
| |
| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 44 | F | Colon | Mucinous adenocarcinoma | 3 | T3N0M0 | IIA | Malignant |
| A2 | 2 | 81 | F | Colon | Mucinous adenocarcinoma | 3 | T4N2M0 | IIIC | Malignant |
| A3 | 3 | 40 | M | Colon | Adenocarcinoma | 3 | T4N2M0 | IIIC | Malignant |
| A4 | 4 | 56 | M | Colon | Adenocarcinoma | 3 | T4N2M0 | IIIC | Malignant |
| A5 | 5 | 35 | M | Colon | Descending colon tissue | * | * | * | Normal |
| A6 | 6 | 69 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| B1 | 7 | 42 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant |
| B2 | 8 | 56 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant |
| B3 | 9 | 50 | F | Breast | Invasive carcinoma of no special type (sparse) | 2 | T4N1M0 | IIIB | Malignant |
| B4 | 10 | 58 | F | Breast | Invasive carcinoma of no special type | 3 | T2N1M0 | IIB | Malignant |
| B5 | 11 | 45 | F | Breast | Adjacent normal breast tissue (adenosis) | * | * | * | NAT |
| B6 | 12 | 54 | F | Breast | Adjacent normal breast tissue (adenosis) | * | * | * | NAT |
| C1 | 13 | 66 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
| C2 | 14 | 70 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
| C3 | 15 | 71 | M | Lung | Acinar adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant |
| C4 | 16 | 58 | F | Lung | Solid adenocarcinoma | 2--3 | T2aN0M0 | IB | Malignant |
| C5 | 17 | 52 | M | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| C6 | 18 | 15 | F | Lung | Lung tissue | * | * | * | Normal |
| D1 | 19 | 73 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score:3+3) | 2 | T3N0M0 | III | Malignant |
| D2 | 20 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:3, Gleason score:3+3) | 1--2 | T3N0M0 | III | Malignant |
| D3 | 21 | 64 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score:3+4) | 2 | T3N0M0 | III | Malignant |
| D4 | 22 | 80 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score:4+5) | 3 | T3N0M0 | III | Malignant |
| D5 | 23 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
| D6 | 24 | 35 | M | Prostate | Prostate tissue | * | * | * | Normal | | Tissue Marker |
|
|
